Sign In

10.7 : Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation reduces it.

Stroke volume, which affects cardiac output, is determined by preload, afterload, and myocardial contractility factors. Preload represents the initial stretching of cardiomyocytes before contraction and is related to left ventricular filling pressure and end-diastolic fiber length. Afterload, or the resistance encountered during blood pumping, is represented by aortic impedance and systemic vascular resistance. The Frank-Starling law states that the stroke volume increases proportionally to the end-diastolic volume, assuming other factors remain constant. This relationship highlights the heart's ability to adjust its output according to the body's needs. Coronary blood flow, vital for providing oxygen and nutrients to the heart, is regulated by several physiological factors. Physical factors include arterial pressure, vascular resistance, and vessel diameter. Metabolite-driven vascular control involves adenosine, nitric oxide, and endothelin, which modulate coronary vasodilation and constriction. Neural and humoral control mechanisms involve neurotransmitters and hormones, further influencing coronary blood flow to maintain heart function. So, cardiovascular drugs can affect cardiac function via alteration of electrophysiology, contraction, oxygen consumption, and coronary blood flow or autonomic control and help treat disorders like heart failure.

Tags
Cardiac PerformanceHeart RateMyocardial ContractionStroke VolumeCardiac OutputPreloadAfterloadMyocardial ContractilityFrank Starling LawCoronary Blood FlowAutonomic Nervous SystemSympathetic ActivationParasympathetic ActivationElectrophysiologyCardiovascular Drugs

From Chapter 10:

article

Now Playing

10.7 : Pathophysiology of Cardiac Performance

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

215 Views

article

10.1 : Electrophysiology of Normal Cardiac Rhythm

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

293 Views

article

10.2 : Mechanism of Cardiac Arrhythmias

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

255 Views

article

10.3 : Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

262 Views

article

10.4 : Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

145 Views

article

10.5 : Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

223 Views

article

10.6 : Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

131 Views

article

10.8 : Pathophysiology of Heart Failure

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

476 Views

article

10.9 : Heart Failure Drugs: Inotropic Agents

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

170 Views

article

10.10 : Heart Failure Drugs: Diuretics

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

119 Views

article

10.11 : Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

122 Views

article

10.12 : Heart Failure Drugs: β-Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

82 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved